cHCC‐CCA
Elizabeth M. Brunt, Shinichi Aishima, Pierre‐Alain Clavien et al. · Hepatology · 2018
Primary liver carcinomas with both hepatocytic and cholangiocytic differentiation have been referred to as "combined (or mixed) hepatocellular-cholangiocarcinoma." These tumors, although described over 100 years ago, have attracted greater attention recently because of interest in possible stem cell origin and perhaps because of greater frequency and clinical recognition. Currently, because of a lack of common terminology in the literature, effective treatment and predictable outcome data have been challenging to accrue. This article represents a consensus document from an international community of pathologists, radiologists, and clinicians who have studied and reported on these tumors and recommends a working terminology for diagnostic and research approaches for further study and evaluation. CONCLUSION: It is recommended that diagnosis is based on routine histopathology with hematoxylin and eosin (H&E); immunostains are supportive, but not essential for diagnosis. (Hepatology 2018;68:113-126).
Cited by 339 works. doi:10.1002/hep.29789 Open-access PDF
Authors
- Elizabeth M. Brunt
- Shinichi Aishima
- Pierre‐Alain Clavien
- Kathryn Jane Fowler
- Zachary D Goodman
- Gregory James Gores
- Annette S.H. Gouw
- Alexander Kagen
- David S. Klimstra
- Mina Komuta
- Fukuo Kondo
- Rebecca Anne Miksad
- Masayuki Nakano
- Yasuni Nakanuma
- Irene Oi‐Lin Ng
- Valérie Paradis
- Young Nyun Park
- Alberto Quaglia
- Massimo G. Roncalli
- Tania Roskams
References
- Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study
- LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
- Cholangiolocellular carcinoma of the liver
- The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin
- Combined hepatocellular and cholangiocarcinoma
- Toward understanding and exploiting tumor heterogeneity
- Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin